Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
about
Role of insulin in the type 2 diabetes therapy: past, present and futureIntensive versus conventional glycaemic control for treating diabetic foot ulcersIntensive versus conventional glycaemic control for treating diabetic foot ulcersEfficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studiesIncretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studiesTeneligliptin in management of type 2 diabetes mellitusPharmacogenetic studies update in type 2 diabetes mellitusMode of administration of dulaglutide: implications for treatment adherenceA Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for PharmacistsCurrent Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with ThiazolidinedionesDiabetes Drugs and Cardiovascular SafetyAdvances in the treatment of type 2 diabetes: impact of dulaglutideEfficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literatureDifferential pharmacology and clinical utility of empagliflozin in type 2 diabetesManagement of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic controlPolypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 DiabetesYoga for Adults with Type 2 Diabetes: A Systematic Review of Controlled TrialsLixisenatide in type 2 diabetes: latest evidence and clinical usefulnessInsulin degludec and insulin aspart: novel insulins for the management of diabetes mellitusCanagliflozin Treatment in Patients with Type 2 Diabetes MellitusWhey protein: The "whey" forward for treatment of type 2 diabetes?New mechanisms of metformin action: Focusing on mitochondria and the gutPlace of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementAdvances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert ForumWhat's next after metformin? focus on sulphonylurea: add-on or combination therapyManagement of diabetic renal diseaseImeglimin: A Potential New Multi-Target Drug for Type 2 DiabetesLessons from mouse models of high-fat diet-induced NAFLDAddressing unmet medical needs in type 2 diabetes: a narrative review of drugs under developmentDeciding oral drugs after metformin in type 2 diabetes: An evidence-based approachAging, diabetes, and the public health system in the United StatesClinical use of pasireotide for Cushing's disease in adultsGLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependenceType 2 diabetes in East Asians: similarities and differences with populations in Europe and the United StatesUse of prednisone with abiraterone acetate in metastatic castration-resistant prostate cancerInsulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetesTreating the elderly diabetic patient: special considerationsGLP-1-based strategies: a physiological analysis of differential mode of actionDiabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomicsThe evolution of insulin glargine and its continuing contribution to diabetes care
P2860
Q22241148-9D58852F-ABF6-415A-A2E1-1A1BAB6C8FCFQ24186487-CCA4CAEB-8B88-42BE-8FEC-4D5C0EA40367Q24197832-4478990F-6701-4E31-9A5E-0AD9E828F9E1Q24288949-69F7D084-369C-453D-89DA-F9117AA7D30CQ24568148-5934049B-18D7-458A-8726-1255B5AEA706Q26738356-FC16A6D1-7C38-4D02-8F91-2AA455720444Q26739350-61F3BCA5-E11C-4017-9498-81AF1C69E86FQ26744065-6BA1C171-6D62-4404-A0C7-B42858E84EECQ26744229-5F77D5F4-8AD2-41E3-B493-409BFB63CE2AQ26745533-9E020274-0516-4A19-85BF-EAB860370997Q26746085-62E086CE-D07C-4421-8AC7-68A9E0543BC0Q26746220-9F15CEB3-2047-4A1E-B739-0F8ECBC5EF63Q26749095-CFEB10D2-E849-42CB-AD72-CB385775451EQ26749281-BC750683-D404-4E5C-A130-39F9EDAE276AQ26766259-CA2F18C1-4319-4E20-8685-871A44759180Q26767283-3AC2447F-92E7-4FBB-AA76-D214DA2CD53BQ26770719-F59F9173-E469-4E55-9D8D-A602E4B797C9Q26771823-5161DB17-7088-4281-96B4-69DDDA77B34BQ26777076-698F0F12-0736-496F-851F-2B75DE46032FQ26777529-85F8B40F-9F90-48C4-9E10-1C2E92234177Q26777875-354955B5-AE83-4A05-BCF3-3DB3939B8D16Q26778766-6FFBE2CD-FAE8-4452-A957-F7A882933EF7Q26783199-A621D857-32EA-4D7B-8508-C599FA78BEF1Q26784022-524632DD-033A-407E-B26E-2D32ADA33A9CQ26786524-FCF761AE-4202-4F8B-ADCF-913381EDF426Q26798436-742F14A3-B81E-4EDE-8D2D-1140D3579B9BQ26800961-62FD8607-D967-40A5-A096-ED8510265138Q26829532-A9C15FC8-4EB4-4486-8D04-EFB501234BE1Q26830274-AFC14660-12F4-4D21-9E85-ACA77BA6B378Q26851797-D690EA45-8E46-4E23-A30C-FEBED08EB7B5Q26852929-2172F786-BEE7-4716-A8DC-A0C2D71CAE50Q26858933-538B6509-8E5F-4437-8100-3D62C6D4575CQ26858990-061D4EEB-0A05-47E1-A339-E77EC8FC983EQ26859746-7F3CBDFF-8A5D-4CE6-9622-9791E3C07168Q26865701-75BAB485-C6C1-4977-B877-5C9C8FD7838EQ26866924-AD6BB6B7-E4F8-424E-BB36-522FED697E59Q26995176-D8C9E86C-62EA-45E5-AB8B-B5278FB02ED1Q26997149-863244E8-750E-4508-8364-E52B37442150Q26998543-72F4B133-54F8-4CA0-986B-23836E5AEC84Q26999454-86B238F8-648D-4B7C-826F-9BB9748CF397
P2860
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Management of hyperglycemia in ...... r the Study of Diabetes (EASD)
@nl
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@ast
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@en
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@en-gb
type
label
Management of hyperglycemia in ...... r the Study of Diabetes (EASD)
@nl
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@ast
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@en
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@en-gb
prefLabel
Management of hyperglycemia in ...... r the Study of Diabetes (EASD)
@nl
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@ast
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@en
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@en-gb
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Management of hyperglycemia in ...... the Study of Diabetes (EASD).
@en
P2093
American Diabetes Association (ADA)
David R Matthews
Ele Ferrannini
European Association for the Study of Diabetes (EASD)
Michael Nauck
Michaela Diamant
Richard M Bergenstal
Richard Wender
Silvio E Inzucchi
P2860
P304
P3181
P356
10.2337/DC12-0413
P407
P5008
P577
2012-04-19T00:00:00Z
2012-06-01T00:00:00Z